Laboratory Tests That Detect Cancer
Since prevention is one of the most important cancer-fighting tools, it is important that cancer be detected as early as possible before it spreads. For warning signs, go to our Cancer Symptoms page.
There are numerous cancer detection and prevention tests that can be used to detect cancer. We are listing the tests that are considered alternative or less toxic than standard conventional tests. Some of these tests are not used by conventional physicians, but you can always ask them to look into the test. It is important to understand that one should not rely on any one test – some tests can result in false positives or negatives. One must take all clinical factors into consideration to back up a diagnosis.
AMAS – Anti-malignin antibody screen test:
Is designed to pick up cancers well in advance of other signs and symptoms, months before conventional medical tests can detect it. However, for advanced cancer, if the antimalignin antibody is wiped out, the test won’t work. For this, other types of testing is recommended. We have also heard of a few breast cancer patients have received a false negative on this test. Again, it is important not to rely on any one test. Oncolab will send a free test kit for you to take to your doctor. The test runs $125 in addition to your doctor’s office charges for drawing blood. Call 1-800-9CATest for a test kit and information.
Biological Terraine Assessment (BTA):
Is a computerized device that measures your blood, saliva and urine for: the amount of electrons present, pH balance, and minerals in these fluids. It will show how healthy your cells are. More specifically, it will show if the cellular environment is too acidic, if there are too few electrons to combat free radicals and/or to produce energy, or if there are too few minerals to buffer the acids. For more information on this test, call (520) 474-4181.
Cancer Marker Tests:
These are immunological methods – cancer markers that are produced as cancer grows and are detectable even before it reaches a size big enough for detection by other methods. This early detection system is vital for early medical intervention that significantly improves the chances of recovery. http://www.pathlab2u.com/s-cancer.shtml discusses these markers, which include:
CBC Blood test lists the amounts detected of about 44 substances normally found in the blood and compares the blood status with known indicators of diseases. For more information on this test, call (702) 832-8485 or 800-208-3444 FREE.
DR-70 is a simple blood test that screens for 13 different cancers at the same time. It is highly specific and catches cancer long before you would suspect anything was amiss. It runs about $100. Cancers that can be detected by the test are of the lung, colon, breast, stomach, liver, rectum, ovary, cervix, esophagus, thyroid, and pancreas, and trophoblast and malignant lymphoma.
AMDL has also received clearance from the FDA to market the PyloriProbe™ test, which can detect the presence of Helicobacter Pylori in the stomach, the primary cause of ulcers and a potential cause of stomach cancer. For more info on the test, contact AMDL Inc., in Tustin, California by calling 714-505-4460, or email them at: email@example.com, or go to their website at www.amdl.com. We are attempting to get information on the accuracy of this test.
ElectroDermal Screening (EDS), is a form of computerized screening based on acupuncture. By taking readings at the different acupuncture points, doctors can tell the health of the organs and of the body itself. Then by having the patient hold substances or remedies while the EDS tests the acupuncture points, the physician can tell what the patient is reacting to and what might heal him or her.
EDS can be used to detect many disease states, plus the presence of chemical toxins, food and substance allergies, and imbalances in the body. Electro-acupuncture biofeedback, a form of EDS has been very successful in screening for a wide variety of conditions. However in screening for cancer it is advisable to also use traditional blood tests, blood analysis with a dark field microscope, and other screening tests. There are a number of naturopaths and alternative physicians that provide EDS screening.
Endoscopic ultrasound is another test being used to detect tumors and help in diagnosing GI cancers. Unlike a traditional endoscope, which looks inside the GI tract, the endoscopic ultrasound looks through the tissue into surrounding organs. Many times, if something is found, a biopsy is done at the same time as an endoscopic ultrasound to determine if it is cancer or just an infection. This technique is also used to help determine the stage of pancreatic cancer without doing surgery. For more information, call: KU Medical Center at (913) 588-1227. As reported by Ivanhoe – www.ivanhoe.com.
Lymphocyte Size Analysis was developed by Valentin Govallo, MD, a Russian immunologist. The test measures the diameters of lymphocytes and counts the numbers of swollen versus normal cells in a sample of a patient’s blood. If the number of swollen lymphocytes is excessive or when the ratio of swollen to normal lymphocytes is out of balance, then cancer will most likely develop. (Note: A lymphocyte is a form of while blood cell whose numbers increase during infection.)
Maverick Monitoring Test (MMT) is a not really a cancer test, but it measures malondialdehyde (MDA) levels in the urine or blood. The amount of MDA tells the physician how much free-radical damage the body has sustained, as well as how the patient is responding to a nutritional anti-oxidant program, based on how much MDA levels decrease while on a particular therapy. Maverick doesn’t diagnose a disease, rather, it highlights the possible preconditions that may contribute to an illness and can help detect a health problem before it occurs. Another interesting thing the test can do is measure the effects of chemotherapy and radiation and help determine the best dosages of antioxidants to counteract these effects. The test costs about $56 and is available by calling (407) 628-3399.
Positron Emission Tomography – PET scan – PET works by providing a dynamic image of the body’s interior. Instead of taking a picture of the bones, like an X-ray, or the internal organs and soft tissue, like a MRI, PET lets doctors visualize the body’s metabolism. Cells use the simple sugar glucose as a source of energy. By tracking how much glucose is metabolized in different areas of the body, PET enables physicians to map the body’s use of the fuel. In order to see the glucose, nuclear medicine physicians attach radioactive tracers to a chemical cousin of glucose. When the mix is injected in a patient, the scanner and computer work together to create an image. Because cancer cells are dividing rapidly, they break down glucose at a much higher rate than most normal cells and the increased activity can show up on a scan. In this way, doctors can see both primary and metastatic tumors.
PET scans differ from conventional CAT because this newer test is better able to detect much smaller, microscopic amounts of cancer cells that have been left over after treatment and to verify that a suspicious mass is truly cancer. CAT, on the other hand, is only able to detect larger masses, and only a surgical procedure, or biopsy, can verify that the CAT-detected mass is cancer. A PET scan can verify that even small masses are cancerous because the technique uses a type of sugar, or glucose, that glows. Cancer cells ingest larger amounts of glucose than normal cells, so they glow “hotter” than normal cells.
So while CAT can identify suspicious masses based on their size, PET scans can identify masses that are cancerous based on their behavior. PET scans can be used in place of biopsy in some patients suspected of having lung cancer, and helps to guide treatment. “PET allows us to see the metabolism of a tumor,” Conti said. “From that we can infer whether it’s benign or malignant, if it has spread or whether treatment has been successful. Note: Medicare has agreed to reimburse for PET scans to stage and diagnose lung cancer. The main concern we have is that this test uses radiation; however, the radiation exposure involved is less than that received from many CT Scan Procedures.
Thermography uses thermal imaging which detects new blood vessels and chemical changes associated with a tumor’s genesis and growth. Thermography measures the radiation of infrared heat from our body and translates this information into anatomical images. Thermography offers a very early warning system, often able to pinpoint a cancer process years before it would be detectable by mammography. This approach can detect cancer when they are at a minute physical stage of development, when it is still relatively easy to halt and reverse the progression of the cancer.
Most breast tumors have been growing slowly for up to 20 years before they are found by typical diagnostic techniques. When used as part of a multi-modal approach (clinical examination + mammography + thermography) 95% of early stage cancers can be detected. However, thermography does not have the ability to pinpoint the location of a tumor.
Consequently, breast thermography’s role is in addition to a ultrasound and physical examination, not in lieu of. For more information on breast thermography, including places to get them done, go to http://www.iact-org.org/breast_thermography.html
T/Tn Antigen Testdeveloped by Dr. Georg Springer can detect the majority of cancers before any biopsy can pick up the presence of cancer. The T and Tn antigens are proteins on the surface of blood and skin cells and can be identified by the immune system antibodies. The concentration of these antigens vary depending on the cancer type and stage.
A skin prick can predict or indicate the likely development of cancers, even 6-10 years in advance of other tests. The test appears to successfully diagnosis about 94% of lung cancers and 80% of breast cancers. More information about the test can be obtained by calling the Chicago Medical School at (847) 578-3435.
Bio-Pulse Clinic expects to be offering an inexpensive blood test called TK-1, which will be sent by mail. This test, involving only one drop of blood, is proving to be very accurate in detecting the presence of cancer in the body, although the exact location of the cancer cannot be determined.
We will update this page when the test is available. Complesys (aka BioPulse) has acquired an exclusive license for the TK1 cancer detection technology from Brigham Young University (worldwide rights), and is moving to commercialize the test as quickly as possible. http://www.complesys.com.
New ultrasonic sensor technology being developed at the University of Illinois Beckman Institute for Advanced Science and Technology may permit the rapid and accurate detection and diagnosis of cancer, without the need of a scalpel. By inserting a miniature probe into a tumor and using pulses of sound waves to image the surrounding tissue, this system could facilitate the early diagnosis of cancer. The ultrasonic microprobe would allow a pathologist to accomplish the same goal as a surgical biopsy but through a rapid and minimally invasive procedure – by inserting the probe into a tumor and displaying the image on a monitor, they could identify and classify the tumor in real time and even send the image over the Internet to specific specialists for help in identification. Go tohttp://www.news.uiuc.edu/scitips/01/05probe.html for more information.
Whole Body CT Scans: There are many companies starting to do whole body scans to detect cancers early. These are being touted as “safe”. However, the FDA has issued a warning that high-tech computerized body imaging for health screening could be exposing the public to risky levels of radiation. It would be better to consider one of the above tests. However, CT scans can be used to replace standard X-rays. Life Extension Foundation in their November magazine had a good issue on these scans. http://www.lef.org/magazine/mag2001/nov2001_awsi.html andhttp://www.lef.org/magazine/mag2001/nov2001_report_scans_01.html
Additional tests to detect specific cancers:
Tests for Bladder Cancer:
Over the past few years, a number of new tests have been devised to aid the diagnosis of bladder cancer. These tests include the bladder-tumor-associated antigen test (BTATM), the BTA stat test, the BTA TRAK® test, the fibrin/fibrinogen degradation products test (FDPTM), and the NMP22TM assay. All of these tests can be performed on urine samples. The BTA® test was designed to detect proteins that are released by reproduction of bladder tumor cells, and its interpretation does not require a technician or specialist. The BTA® test significantly identifies superficial (surface) bladder tumors by changing color.
The top of the BTA® test strip turns yellow when positive for bladder cancer, and it turns green when negative. The BTA stat test is an immunologic assay that can be used to identify recurrent bladder cancer. The FDP® test detects the breakdown products of blood-clotting proteins (fibrin, fibrinogen), which are increased in the urine in the presence of bladder cancer. The NMP22TM assay measures specific proteins from the nuclear matrix (cell center).
It can detect transitional cell carcinoma (TCC) with a sensitivity of roughly 67%, meaning that 67% of existing TCCs are detected. But, perhaps more importantly, the NMP22TM assay it is able to predict the recurrence of bladder cancer For more information go to http://www.urologychannel.com/bladdercancer/diagnosis.shtml.
New protein test could be twice as accurate in detecting bladder cancer according to a report in the Scotsman 07/17/2002 and Tests for Breast Cancer:
The CTLM – Computed Tomography Laser Mammography system uses state-of-the-art laser technology, a special array of detectors and proprietary computed algorithms. The CTLM® system does not expose the patient to ionizing radiation or require breast compression. This approach is awaiting FDA approval.
Digital mammography still uses low energy x-rays that pass through the breast exactly like conventional mammograms but are recorded by means of an electronic digital detector instead of the film. This electronic image can be displayed on a video monitor like a TV or printed onto film. The radiologist can manipulate the digital mammogram electronically to magnify an area, change contrast, or alter the brightness.
A number of other imaging methods are now available for detecting breast cancer. At present, they are used mainly in research studies, and sometimes to get more information about a tumor found by another method. Each of these new methods generates a computerized image that the doctor can analyze for the presence of an abnormal breast lump. These include:
Also called scintimammography, this test uses a special camera to show where a tracer (a radioactive chemical) has adhered to a tumor. A scanner is then used to see if the breast lump has picked up more of the radioactive material than the rest of the breast tissue. Dr. Fleming in Omaha has been using this approach. There are also clinical trials for this approach.
A magnetic resonance imaging (MRI) machine uses a large magnet and radio waves to measure the electromagnetic signals your body naturally gives off. It makes precise images of the inside of the body, including tissue and fluids. MRI can also be used to see if a silicone breast implant has leaked or ruptured.
Tests for Colon/Colorectal Cancer:
Tests for Lung Cancer:
Tests for Oral Cancer:
Doctors at the University of Oslo have found an easy way to predict one of the world’s most deadly cancers – oral cancer by counting chromosomes. This test is being done in Canada and may receive approval in the states.
Tests for Ovarian and Cervical Cancer:
Cancer Marker for Nasophryngeal Cancer:
Cancer Marker for Pancreatic/Stomach Cancer:
Tests for Prostate Cancer:
Tests for Thyroid Cancer:Tests for Tests for Thyroid Cancer:
If you are aware of any other tests that we should research, be sure to email our webmaster or call us at (800) 282-2873FREE.
Affiliate Disclosure: Advertising: Our Beliefs: PMA
TOP NATURAL CANCER PROTOCOLS
Do you like the info we share here? Was it of benefit to you? Support our efforts with a donation. Let's keep the information flowing. Any amount helps. Thank you.
This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional.
Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website.
The protocols described on this website are for adult use only, unless otherwise specified. Protocol or product labels may contain important safety information and the most recent information provided by the linked product manufacturers, should be carefully reviewed prior to use to verify the usage rate, administration, and contraindications.
National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from ANY protocols listed on this website, and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.
The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. JA Health Advocate has not performed independent verification of the data contained in the referenced materials, and expressly disclaims responsibility for any error in any of the shared literature.
The information contained herein is not intended to replace a one-on-one relationship with a doctor or qualified healthcare professional. Therefore, this information is not intended as medical advice, but rather a sharing of knowledge and information based on research and experience. JA Health Advocate encourages you to make your own health care decisions based on your judgment and research in partnership with a qualified healthcare professional.
The CLO2 Protocols described on this site are for informational purposes ONLY. The reader accepts 100% responsibility for any and all use made of any information herein.
These statements have not been evaluated by the US Food and Drug Administration or the Jamaica Ministry of Health. The information on this website is not intended to diagnose, treat, cure or prevent any disease. They should not replace personal judgment nor medical treatment, nor are they intended to diagnose, treat, cure, or prevent any disease. Always talk to your Natural Health Provider or M.D. about the use of these or any other complimentary modalities. Reading this website denotes your understanding and agreement to our full disclaimer.
You should contact a trained professional who understands how to safely and effectively use CLO2 and it's derivatives.
The FDA Considers MMS/CD - Chlorine Dioxide as SAFE for Humans
FDA Patents for MMS/CD - Chlorine Dioxide for Cancer Care
FDA Patent: Chlorine dioxide gas for use in treating respiratory virus infection
FDA Patent: Apparatus and method for disinfecting water
FDA Patent for HIV Treatment
FDA Patent for inflammatory diseases
However, these chemicals are hazardous materials that must be handled with respect. In addition, usage rates and guidelines must be understood and followed carefully. Myself and many other individuals have found we could learn to use chlorine dioxide effectively, but this has yet to be recognized by government authorities. My recommendation is for you to find a doctor who will be on board and supportive of using any of the self-help techniques you may find on this site.
We do not sell products, but we do supply you with links to approved suppliers who we buy from too.
Copyright © 2020 JA Health Advocate · All Rights Reserved · Powered by DebsWebDesign